Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Mangoceuticals (MGRX) Interest Expenses (2025)

Mangoceuticals (MGRX) has disclosed Interest Expenses for 1 consecutive years, with $19663.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses changed N/A to $19663.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $103513.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $103513.0 for FY2025, 655.57% up from the prior year.
  • Interest Expenses hit $19663.0 in Q4 2025 for Mangoceuticals, down from $75850.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $75850.0 in Q3 2025 to a low of -$13700.0 in Q1 2025.